Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso

Clinical trial NCT03950739 · COMPLETED

Trial details

NCT number: NCT03950739
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2019-09-17
Primary completion: 2023-08-22
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.